Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-2-((methyl-13C-d3)carbamoyl)pyridine 1-oxide
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Yes -Refer MSDS for accurate information
Regorafenib-13C,d3 N-Oxide is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Regorafenib-13C,d3 N-Oxide usage and description
Regorafenib 13CD3 N-Oxide is a chemical compound that is widely used as a kinase inhibitor in the treatment of various types of cancer. The drug works by inhibiting several protein kinases that play a crucial role in the growth and spread of cancer cells. Regorafenib 13CD3 N-Oxide is a derivative of regorafenib, which is a potent inhibitor of multiple kinases involved in angiogenesis, tumor growth, and metastasis.
The chemical formula of Regorafenib 13CD3 N-Oxide is C21H13D3ClF4N4O3, and its molecular weight is 476.84 g/mol. The compound is a stable, white to off-white powder with a melting point of 147°C to 152°C. Regorafenib 13CD3 N-Oxide is soluble in dimethyl sulfoxide and methanol but has limited solubility in water.
The recommended dosage of Regorafenib 13CD3 N-Oxide varies depending on the type and stage of cancer being treated. The drug is administered orally, and it is usually taken once a day for 21 days, followed by a 7-day break. The treatment cycle is repeated until the cancer is under control or until the patient experiences adverse effects.
Like other cancer drugs, Regorafenib 13CD3 N-Oxide can cause side effects such as fatigue, diarrhea, nausea, vomiting, and loss of appetite. It is important to inform the doctor immediately if any adverse symptoms occur during the treatment. Overall, Regorafenib 13CD3 N-Oxide is a promising drug that has shown significant efficacy in the treatment of various types of cancer, and ongoing research is being conducted to explore its full potential.
